Advances in Morbidity and Mortality of Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Survivorship and Quality of Life".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 1074
Special Issue Editors
Interests: thyroid carcinoma; liposarcoma; gastroenteropancreatic neuroendocrine tumor; NET; pancreatic cancer; colorectal cancer; gastric cancer; apoptosis; programmed cell death; metastasis
Special Issue Information
Dear Colleagues,
This Special Issue, entitled “Advances in Morbidity and Mortality of Cancers”, highlights the complex interrelationships and challenges faced in the diagnosis, treatment, and aftercare of cancer. It is dedicated to examining the burden of disease (morbidity) and mortality associated with different types of cancer. The aim of this Special Issue is to present new research findings, clinical trials, and innovative approaches to improving the care and survival of cancer patients.
It focuses on topics such as the impact of cancer on quality of life, the role of comorbidities, differences in cancer mortality between different population groups and advances in prevention, early detection, and treatment. In addition, the importance of interdisciplinary approaches to reduce cancer mortality and improve long-term prognosis will be discussed.
This Special Issue is aimed at oncologists, surgeons, epidemiologists, healthcare providers, and researchers involved in the epidemiology, treatment, and prevention of cancer. It will provide a comprehensive analysis of the current challenges and future prospects in the fight against cancer and emphasizes the need for further research and collaboration on a global scale to sustainably reduce cancer morbidity and mortality.
Prof. Dr. Andreas Krieg
Guest Editor
Dr. Sarah Krieg
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- morbidity
- mortality
- cancers diagnosis
- cancers treatment
- cancers aftercare
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.